版本:
中国

BRIEF-Nuvo Pharmaceuticals announces district court decision to uphold U.S. Pennsaid 2% patent

May 15 Nuvo Pharmaceuticals Inc

* Nuvo Pharmaceuticals announces district court decision to uphold U.S. Pennsaid 2% patent

* Court upheld validity of Horizon Pharma's U.S. patent covering Pennsaid 2%

* Pennsaid 2% has multiple orange book listed patents with terms that extend to 2030 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐